Plante Moran Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-6
| Closed | -$1K | – | 915 |
|
2020
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 715 |
|
2019
Q4 | – | Sell |
-25
| Closed | -$2K | – | 942 |
|
2019
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 805 |
|
2019
Q2 | $3K | Sell |
25
-3
| -11% | -$360 | ﹤0.01% | 711 |
|
2019
Q1 | $4K | Sell |
28
-23
| -45% | -$3.29K | ﹤0.01% | 671 |
|
2018
Q4 | $5K | Buy |
51
+22
| +76% | +$2.16K | ﹤0.01% | 611 |
|
2018
Q3 | $4K | Sell |
29
-27
| -48% | -$3.72K | ﹤0.01% | 624 |
|
2018
Q2 | $7K | Sell |
56
-65
| -54% | -$8.13K | ﹤0.01% | 596 |
|
2018
Q1 | $13K | Buy |
121
+56
| +86% | +$6.02K | 0.01% | 570 |
|
2017
Q4 | $8K | Hold |
65
| – | – | ﹤0.01% | 643 |
|
2017
Q3 | $9K | Hold |
65
| – | – | 0.01% | 567 |
|
2017
Q2 | $8K | Hold |
65
| – | – | 0.01% | 601 |
|
2017
Q1 | $8K | Hold |
65
| – | – | ﹤0.01% | 631 |
|
2016
Q4 | $8K | Hold |
65
| – | – | 0.01% | 635 |
|
2016
Q3 | $8K | Sell |
65
-11
| -14% | -$1.35K | 0.01% | 629 |
|
2016
Q2 | $9K | Buy |
76
+11
| +17% | +$1.3K | 0.01% | 548 |
|
2016
Q1 | $9K | Hold |
65
| – | – | 0.01% | 503 |
|
2015
Q4 | $12K | Sell |
65
-47
| -42% | -$8.68K | 0.01% | 545 |
|
2015
Q3 | $18K | Buy |
112
+47
| +72% | +$7.55K | 0.01% | 395 |
|
2015
Q2 | $12K | Hold |
65
| – | – | 0.01% | 502 |
|
2015
Q1 | $11K | Hold |
65
| – | – | 0.01% | 509 |
|
2014
Q4 | $12K | Hold |
65
| – | – | 0.01% | 507 |
|
2014
Q3 | $11K | Sell |
65
-14
| -18% | -$2.37K | 0.01% | 527 |
|
2014
Q2 | $12K | Buy |
79
+65
| +464% | +$9.87K | 0.01% | 488 |
|
2014
Q1 | $2K | Hold |
14
| – | – | ﹤0.01% | 567 |
|
2013
Q4 | $2K | Hold |
14
| – | – | ﹤0.01% | 638 |
|
2013
Q3 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 576 |
|